中国组织工程研究
中國組織工程研究
중국조직공정연구
Journal of Clinical Rehabilitative Tissue Engineering Research
2013年
49期
8520-8526
,共7页
武丽萍%蔡力%陶剑虹%曹玫%朱一帆%李进嵩%王艳
武麗萍%蔡力%陶劍虹%曹玫%硃一帆%李進嵩%王豔
무려평%채력%도검홍%조매%주일범%리진숭%왕염
干细胞%干细胞移植%人脐带间充质干细胞%HLA-G%心肌梗死%血运重建%省级基金%干细胞图片文章
榦細胞%榦細胞移植%人臍帶間充質榦細胞%HLA-G%心肌梗死%血運重建%省級基金%榦細胞圖片文章
간세포%간세포이식%인제대간충질간세포%HLA-G%심기경사%혈운중건%성급기금%간세포도편문장
背景:干细胞移植有利于心肌梗死后的心肌血运重建及改善心功能,HLA-G分子在免疫耐受状态的形成及维持中具有重要作用。<br> 目的:观察不同月龄有HLA-G表达差异的人脐带间充质干细胞移植后对急性心肌梗死兔血运重建的影响。<br> 方法:健康新西兰大白兔30只,随机数字表法分为小月龄细胞移植组、足月龄细胞移植组及对照组。建立兔心肌梗死模型后2周,将小月龄人脐带间充质干细胞和足月人脐带间充质干细胞分别标记BrdU,多点注射心肌梗死的交界区和中心区,对照组注射无血清培养基。<br> 结果与结论:移植后4周,小月龄和足月龄细胞移植组在心肌梗死区均发现有 BrdU 示踪细胞,且两组梗死区心肌纤维化程度、心肌梗死面积均少于对照组(P <0.01),两移植组间差异也有显著性意义(P <0.05)。Ⅷ因子染色见小月龄细胞移植组毛细血管密度高于足月龄细胞移植组(P<0.01),且两移植组与对照组比较差异也有显著性意义(P<0.05)。提示HLA-G表达量较高的小月龄脐带间充质干细胞能更好促进梗死区血管新生,改善血运重建,有潜力成为心肌细胞移植的更理想来源。
揹景:榦細胞移植有利于心肌梗死後的心肌血運重建及改善心功能,HLA-G分子在免疫耐受狀態的形成及維持中具有重要作用。<br> 目的:觀察不同月齡有HLA-G錶達差異的人臍帶間充質榦細胞移植後對急性心肌梗死兔血運重建的影響。<br> 方法:健康新西蘭大白兔30隻,隨機數字錶法分為小月齡細胞移植組、足月齡細胞移植組及對照組。建立兔心肌梗死模型後2週,將小月齡人臍帶間充質榦細胞和足月人臍帶間充質榦細胞分彆標記BrdU,多點註射心肌梗死的交界區和中心區,對照組註射無血清培養基。<br> 結果與結論:移植後4週,小月齡和足月齡細胞移植組在心肌梗死區均髮現有 BrdU 示蹤細胞,且兩組梗死區心肌纖維化程度、心肌梗死麵積均少于對照組(P <0.01),兩移植組間差異也有顯著性意義(P <0.05)。Ⅷ因子染色見小月齡細胞移植組毛細血管密度高于足月齡細胞移植組(P<0.01),且兩移植組與對照組比較差異也有顯著性意義(P<0.05)。提示HLA-G錶達量較高的小月齡臍帶間充質榦細胞能更好促進梗死區血管新生,改善血運重建,有潛力成為心肌細胞移植的更理想來源。
배경:간세포이식유리우심기경사후적심기혈운중건급개선심공능,HLA-G분자재면역내수상태적형성급유지중구유중요작용。<br> 목적:관찰불동월령유HLA-G표체차이적인제대간충질간세포이식후대급성심기경사토혈운중건적영향。<br> 방법:건강신서란대백토30지,수궤수자표법분위소월령세포이식조、족월령세포이식조급대조조。건립토심기경사모형후2주,장소월령인제대간충질간세포화족월인제대간충질간세포분별표기BrdU,다점주사심기경사적교계구화중심구,대조조주사무혈청배양기。<br> 결과여결론:이식후4주,소월령화족월령세포이식조재심기경사구균발현유 BrdU 시종세포,차량조경사구심기섬유화정도、심기경사면적균소우대조조(P <0.01),량이식조간차이야유현저성의의(P <0.05)。Ⅷ인자염색견소월령세포이식조모세혈관밀도고우족월령세포이식조(P<0.01),차량이식조여대조조비교차이야유현저성의의(P<0.05)。제시HLA-G표체량교고적소월령제대간충질간세포능경호촉진경사구혈관신생,개선혈운중건,유잠력성위심기세포이식적경이상래원。
BACKGROUND:Transplantation of stem cells has a beneficial effect on myocardium revascularization and improving cardiac function after myocardial infarction, and HLA-G protein contributes to the formation and maintenance of the immune tolerance. <br> OBJECTIVE:To investigate the transplantation effects of human umbilical cord mesenchymal stem cells at different gestational age with different HLA-G expression levels on myocardium revascularization after myocardial infarction in rabbits. <br> METHODS:Thirty healthy New Zealand rabbits were selected and were randomly divided into human smal gestational age umbilical cord-derived mesenchymal stem cells transplantation group, human ful-term umbilical cord-derived mesenchymal stem cells transplantation group and control group. After the rabbits models of acute myocardial infarction had been established, the former two groups were infused different umbilical cord-derived human umbilical cord mesenchymal stem cells labeled with 5-bromo-2-deoxyuridine into the edge and center of myocardial infarct region by multipoint injection. Rabbits in the control group were subjected to an equal volume of serum-free culture medium. <br> RESULTS AND CONCLUSION:Four weeks after celltransplantation, 5-bromo-2-deoxyuridine-positive cells were found surrounding the infarct site in both transplantation groups. Myocardial fibrosis and myocardial infarct size were significantly lower in both transplantation groups than those of the control group (P<0.05), and there was a significant difference between the two transplantation groups (P<0.01). The positive staining of factor VII indicated that capil ary density was increased significantly in the smal gestational age umbilical cord-derived mesenchymal stem cells transplantation group as compared with the ful-term umbilical cord-derived mesenchymal stem cells transplantation group (P<0.01), and a sstatistical difference was found between two transplantation groups and the control group (P<0.01). Transplantation of human umbilical cord mesenchymal stem cells with high HLA-G expression increases new capil ary vessels and improves myocardium revascularization. Al indicate that human smal gestational age umbilical cord mesenchymal stem cells have the potential to become the better source of cardiomyocytes transplantation.